Kidneycan
kidney cancer research
Based in PA
🤖
AI Overview
With $240K in lobbying spend across 14 quarterly filings, Kidneycan is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2025.
$240K
Total Spend
4
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $40K |
| 2023 | $80K |
| 2024 | $80K |
| 2025 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED
- •kidney cancer research
- •HR 8295/S no bill #, FY23 Labor-HHS-Education Appropriations Act, kidney cancer research at NIH
- •FY24 Labor-HHS-Education Appropriations Act, kidney cancer research at NIH
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.